Aumolertinib Versus Osimertinib As First-line Therapy for Patients with EGFR Mutated Locally Advanced or Metastatic Non-small-cell Lung Cancer
Clinical trial NCT06752408 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06752408
- Sponsor
- Peking Union Medical College Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-17
- Primary completion
- 2027-01-16
- Enrollment
- 316
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.